Alamar Biosciences, Inc.(ALMR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ALMR Alamar Biosciences, Inc.

盘后交易 05-13 17:05:51 EDT

23.01

+0.04

+0.17%

盘后23.15

+0.14+0.61%

16:14 EDT

最高24.88	最低22.75	成交量22.21万
今开22.99	昨收22.97	日振幅9.27%
总市值15.95亿	流通市值2.16亿	总股本6,931万
成交额523.58万	换手率2.37%	流通股本937.50万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ALMR","market":"US","secType":"STK","nameCN":"Alamar Biosciences, Inc.","latestPrice":23.01,"timestamp":1778702400000,"preClose":22.97,"halted":0,"volume":222135,"hourTrading":{"tag":"盘后","latestPrice":23.15,"preClose":23.01,"latestTime":"16:14 EDT","volume":2473,"amount":56905.41164,"timestamp":1778703249660,"change":0.14,"changeRate":0.006084,"amplitude":0.006084},"delay":0,"changeRate":0.0017414018284720376,"floatShares":9375000,"shares":69311200,"eps":-0.627,"marketStatus":"盘后交易","change":0.04,"latestTime":"05-13 17:05:51 EDT","open":22.99,"high":24.88,"low":22.75,"amount":5235801.6442,"amplitude":0.09273,"askPrice":23.44,"askSize":1,"bidPrice":23.15,"bidSize":109,"shortable":3,"etf":0,"ttmEps":-0.627,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1778716800000},"marketStatusCode":4,"adr":0,"listingDate":1776398400000,"exchange":"NASDAQ","adjPreClose":22.97,"preHourTrading":{"tag":"盘前","latestPrice":22.97,"preClose":22.97,"latestTime":"09:29 EDT","volume":160,"amount":3719.82,"timestamp":1778678943111,"change":0,"changeRate":0,"amplitude":0.032216},"postHourTrading":{"tag":"盘后","latestPrice":23.15,"preClose":23.01,"latestTime":"16:14 EDT","volume":2473,"amount":56905.41164,"timestamp":1778703249660,"change":0.14,"changeRate":0.006084,"amplitude":0.006084},"volumeRatio":0.955792},"requestUrl":"/m/hq/s/ALMR","defaultTab":"news","newsList":[{"id":"1180385750","title":"美银全球研究开始覆盖Alamar Biosciences，给予中性评级及27美元目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1180385750","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180385750?lang=zh_cn&edition=full","pubTime":"2026-05-12 19:51","pubTimestamp":1778586675,"startTime":"0","endTime":"0","summary":"美银全球研究（BofA Global Research）已开始对生物科技公司Alamar Biosciences进行跟踪研究，并在其首份报告中给予该公司“中性”评级。与此同时，分析师为该股设定了27美元的目标价位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147513482","title":"Leerink Partners首予Alamar Biosciences“跑赢大盘”评级，目标价35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1147513482","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147513482?lang=zh_cn&edition=full","pubTime":"2026-05-12 18:07","pubTimestamp":1778580462,"startTime":"0","endTime":"0","summary":"投资银行Leerink Partners宣布，首次覆盖生物科技公司Alamar Biosciences，并给予其“跑赢大盘”的评级。该机构为该公司设定了35美元的目标股价。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186885979","title":"异动解读 | Alamar Biosciences IPO后受技术优势及投资者信心推动，盘中大涨5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1186885979","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186885979?lang=zh_cn&edition=full","pubTime":"2026-04-20 22:16","pubTimestamp":1776694619,"startTime":"0","endTime":"0","summary":"Alamar Biosciences, Inc.（股票代码：ALMR）今日盘中股价大幅上涨5.00%，市场表现强劲。消息面上，该公司于近期成功登陆纳斯达克，完成首次公开募股（IPO）。作为精准蛋白质组学领域的领导者，Alamar Biosciences自主研发的NULISA™技术平台在蛋白质检测方面具有超高灵敏度与特异性，其ARGO™ HT全自动高通量设备也已实现广泛的市场渗透，累计装机量超过100台，客户遍布全球25个国家。此外，知名风险投资机构启明创投作为公司重要的早期投资方，持续多轮支持其发展，并在IPO前持有约19.2%的股份，这进一步增强了市场对该公司长期成长潜力的信心。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628716309","title":"精准蛋白质组学领域领导者Alamar Biosciences成功登陆纳斯达克","url":"https://stock-news.laohu8.com/highlight/detail?id=2628716309","media":"美通社","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628716309?lang=zh_cn&edition=full","pubTime":"2026-04-20 10:28","pubTimestamp":1776652080,"startTime":"0","endTime":"0","summary":"上海2026年4月20日 /美通社/ -- 北京时间2026年4月17日，启明创投投资企业、精准蛋白质组学领域领导者Alamar Biosciences成功登陆纳斯达克，至此启明创投迎来开年第五个IPO。2020年，启明创投领投了Alamar Biosciences的A轮融资，并在B轮和C轮继续支持公司发展。IPO前启明创投持有Alamar Biosciences约19.2%的股份，是公司最重要的机构投资方之一。Alamar Biosciences成立于2018年，该公司致力于开发并商业化蛋白质组学技术，树立蛋白质检测与分析领域的金标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/4937755_ZH37755_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["NVIW.SI","TQQY","QQQM","QQQ","QQQE","BK4007","QLD","NQmain","QQQJ","ONEQ","QQQY","MNQmain","ALMR","QDTE","SQQQ","QID","TQQQ","GPIQ","JEPQ","QQQA","FTEC","BK1147","PSQ","QYLG","IYW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628665157","title":"生物医药企业Alamar纳斯达克上市：市值14亿美元 年亏2982万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2628665157","media":"雷递网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628665157?lang=zh_cn&edition=full","pubTime":"2026-04-19 15:39","pubTimestamp":1776584368,"startTime":"0","endTime":"0","summary":"精准蛋白质组学领域Alamar Biosciences（股票代码为“ALMR”）日前在美国纳斯达克上市。","market":"us","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260419/6391220993276710514400681.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260419/6391220993276710514400681.jpeg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n33339/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["ALMR","MNQmain","BK4585","NQmain","BK4007","PSQ","QLD","QQQY","JEPQ","QQQA","GPIQ","QQQ","QQQM","QYLG","FTEC","NVIW.SI","BK1147","QQQJ","SQQQ","QQQE","BK4581","BK4588","QID","IYW","TQQY","TQQQ","ONEQ","QDTE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107620656","title":"异动解读 | IPO首秀开盘价高于发行价，Alamar Biosciences盘中大涨32.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=1107620656","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107620656?lang=zh_cn&edition=full","pubTime":"2026-04-18 00:37","pubTimestamp":1776443855,"startTime":"0","endTime":"0","summary":"Alamar Biosciences, Inc.（股票代码：ALMR）今日盘中股价大幅上涨32.94%，引起了市场的广泛关注。消息面上，该公司今日在纳斯达克首次公开募股（IPO）上市。其股票发行价为每股17美元，而市场预计的开盘价达到22.50美元，显著高于发行价。此次IPO以发行区间上限价格出售了约1130万股股票，成功募集资金约1.913亿美元。Alamar Biosciences是一家专注于蛋白质组学的公司，开发了用于检测血液中低水平蛋白质生物标记物的仪器平台，该技术为疾病研究和诊断提供了有力工具。市场对其技术和增长前景的乐观情绪，推动了上市首日的强劲表现。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628783908","title":"美股异动 | Alamar Biosciences(ALMR.US)登陆美股市场 开盘涨超34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628783908","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628783908?lang=zh_cn&edition=full","pubTime":"2026-04-18 00:07","pubTimestamp":1776442021,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周五，Alamar Biosciences(ALMR.US)登陆美股市场，开盘涨超34%，报22.91美元。IPO价格为17美元。Alamar Biosciences是一家总部位于美国加州的生物科技公司，专注于精准蛋白质组学技术的开发与应用。公司核心产品基于自研的NULISA平台，能够以极高灵敏度检测血液中的微量蛋白质标志物，从而帮助科研人员更早发现疾病、推动药物研发和精准医疗发展。其技术主要应用于阿尔茨海默症、帕金森等神经退行性疾病研究领域。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1430272.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["ALMR"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.alamarbio.com","stockEarnings":[{"period":"1week","weight":-0.0389},{"period":"1month","weight":0.3512},{"period":"ytd","weight":0.3512}],"compareEarnings":[{"period":"1week","weight":0.0199},{"period":"1month","weight":0.0864},{"period":"3month","weight":0.0668},{"period":"6month","weight":0.0984},{"period":"1year","weight":0.2662},{"period":"ytd","weight":0.0825}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Alamar Biosciences, Inc.于2018年5月7日在特拉华州注册成立，总部位于加利福尼亚州弗里蒙特市。该公司是一家商业化阶段的蛋白质组学公司，致力于建立蛋白质检测和分析的黄金标准。公司提供专有的NULISA平台，该平台能够以超高灵敏度、高特异性、灵活的多重检测、宽动态范围和自动化，检测非侵入性生物体液中的低丰度蛋白质生物标志物，从而实现“精准蛋白质组学”。公司提供仪器、耗材和分析软件的集成解决方案，用于发现、转化研究和诊断开发。","exchange":"NASDAQ","name":"Alamar Biosciences, Inc.","nameEN":"Alamar Biosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Alamar Biosciences, Inc.(ALMR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Alamar Biosciences, Inc.(ALMR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Alamar Biosciences, Inc.,ALMR,Alamar Biosciences, Inc.股票,Alamar Biosciences, Inc.股票老虎,Alamar Biosciences, Inc.股票老虎国际,Alamar Biosciences, Inc.行情,Alamar Biosciences, Inc.股票行情,Alamar Biosciences, Inc.股价,Alamar Biosciences, Inc.股市,Alamar Biosciences, Inc.股票价格,Alamar Biosciences, Inc.股票交易,Alamar Biosciences, Inc.股票购买,Alamar Biosciences, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Alamar Biosciences, Inc.(ALMR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Alamar Biosciences, Inc.(ALMR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}